Guokui Li

Title: Guokui Li: Innovator in Pharmaceutical Chemistry

Introduction

Guokui Li is a prominent inventor based in Yunnan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on metalloporphyrin compounds. His research focuses on the preparation and application of these compounds, which have important implications for medical science.

Latest Patents

Guokui Li holds a patent for a metalloporphyrin compound, which is detailed in his disclosure titled "Metalloporphyrin compounds, preparation and uses thereof." This patent relates to the ability of the metalloporphyrin compound to specifically recognize HIV RNA and effectively inhibit HIV reverse transcriptase. The compound can exist in various forms, including optical isomers, pharmaceutically-acceptable salts, or solvates. This innovation provides a basis for developing reagents that selectively recognize HIV TAR RNA and serve as inhibitors of HIV reverse transcriptase.

Career Highlights

Guokui Li is affiliated with Yunnan University, where he continues to advance his research in pharmaceutical chemistry. His work has garnered attention for its potential to contribute to the fight against HIV, a significant global health challenge. With a focus on innovative solutions, he has established himself as a key figure in his field.

Collaborations

Guokui Li collaborates with notable colleagues, including Feng Gao and Xudan Bi. These partnerships enhance the research efforts and broaden the impact of their work in pharmaceutical chemistry.

Conclusion

Guokui Li's contributions to the field of pharmaceutical chemistry, particularly through his patent on metalloporphyrin compounds, highlight his role as an innovator in addressing critical health issues. His ongoing research at Yunnan University continues to pave the way for advancements in medical science.